# Atossa Therapeutics, Inc. (ATOS)

> Healthcare · US · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/ATOS/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2026 | $ 0 | $ -18.08M | $ -19.23M | $ 0 | $ 26.83M |
| 2025 | $ 0 | $ -35.60M | $ -30.50M | $ 0 | $ 39.35M |
| 2024 | $ 0 | $ -26.81M | $ -22.12M | $ 0 | $ 71.48M |
| 2023 | $ 0 | $ -32.54M | $ -22.66M | $ 0 | $ 91.02M |
| 2022 | $ 0 | $ -30.12M | $ -23.22M | $ 0 | $ 117.96M |
| 2021 | $ 0 | $ -24.49M | $ -19.59M | $ 0 | $ 138.14M |
| 2020 | $ 0 | $ -22.71M | $ -14.75M | $ 18.1K | $ 27.17M |
| 2019 | $ 0 | $ -22.25M | $ -11.79M | $ 50.5K | $ 13.16M |
| 2018 | $ 0 | $ -15.06M | $ -11.98M | $ 0 | $ 8.81M |
| 2017 | $ 0 | $ -10.94M | $ -8.88M | $ 0 | $ 6.94M |
| 2016 | $ 0 | $ -8.76M | $ -7.41M | $ 0 | $ 3.10M |
| 2015 | $ 2.5K | $ -22.13M | $ -19.77M | $ 0 | $ 3.74M |
| 2014 | $ 56.7K | $ -20.71M | $ -15.40M | $ 125.2K | $ 9.50M |
| 2013 | $ 899.6K | $ -15.34M | $ -13.26M | $ 15.5K | $ 10.60M |
| 2012 | $ 672.5K | $ -7.33M | $ -5.82M | $ 0 | $ 5.18M |
| 2011 | $ 2.2K | $ -5.09M | $ -5.23M | $ 1.01M | $ 1.56M |
| 2010 | $ 0 | $ -1.55M | $ -308.7K | $ 189.0K | $ -851.9K |
| 2009 | $ 0 | $ -140.2K | N/A | N/A | N/A |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | 0.00 |
| Liabilities / Eq | 0.20 |
| Current Ratio | 5.69 |

## Other views

- [Metrics](https://sponda.capital/en/ATOS.md)
- [Charts](https://sponda.capital/en/ATOS/charts.md)
- [Compare](https://sponda.capital/en/ATOS/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-29.